BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37103638)

  • 1. A case of rapidly progressive glomerulonephritis with double-positive anti-GBM antibody and MPO-ANCA after SARS-CoV-2 vaccination and relapse during 1 year follow-up.
    Terakawa K; Niikura T; Katagiri D; Sugita A; Kikuchi T; Hayashi A; Suzuki M; Takano H
    CEN Case Rep; 2024 Feb; 13(1):19-25. PubMed ID: 37103638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases.
    Nakabayashi K; Fujioka Y; Nagasawa T; Kimura T; Kojima K; Arimura Y; Yamada A
    Clin Exp Nephrol; 2011 Apr; 15(2):226-34. PubMed ID: 21246240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA-associated pachymeningitis].
    Yamazaki C; Arai S; Tamura Y; Suzuki Y; Nakajima H; Kojima K; Uchida S
    Nihon Jinzo Gakkai Shi; 2009; 51(4):490-5. PubMed ID: 19601559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA positive interstitial pneumonia].
    Yamazaki K; Kanehira K; Inaba Y; Shimizu J; Sugiyama N
    Nihon Jinzo Gakkai Shi; 2012; 54(8):1203-8. PubMed ID: 23387284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
    Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
    Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of progressive systemic sclerosis with crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) and anti-glomerular basement membrane antibody (anti-GBM Ab)].
    Kobayashi M; Saito M; Minoshima S; Arimura Y; Nagasawa T
    Nihon Jinzo Gakkai Shi; 1995 Mar; 37(3):207-11. PubMed ID: 7731110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An experience of treatment of double positive myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) and anti-glomerular basement membrane antibodies in Goodpasture's syndrome onset of crescentic glomerulonephritis].
    Takeda T; Takeda T; Naiki Y; Yonekawa S; Sakaguchi M; Iwamoto I; Tanaka H; Hasegawa H; Imada A; Kanamaru A; Hiruma S; Maekura S; Hashimoto S; Yamazumi T
    Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):591-6. PubMed ID: 9893458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unusual presentation of propylthiouracil-induced anti-MPO and PR3 positive ANCA vasculitis with associated anti-GBM antibodies, IgA nephropathy and an IgG4 interstitial infiltrate: a case report.
    Galante JR; Daruwalla CP; Roberts ISD; Haynes R; Storey BC; Bottomley MJ
    BMC Nephrol; 2020 Jul; 21(1):295. PubMed ID: 32703233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-glomerular Basement Membrane Disease Concomitant with MPO-ANCA Positivity Concurrent with High Serum Levels of Interleukin-26 Following Coronavirus Disease 2019 Vaccination.
    Kobayashi S; Fugo K; Hatano R; Yamazaki K; Morimoto C; Terawaki H
    Intern Med; 2023 Apr; 62(7):1043-1048. PubMed ID: 36725042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-Positive Anti-Glomerular Basement Membrane Antibody and Myeloperoxidase Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis Post COVID-19 mRNA vaccine: A Case Series of 4 Patients.
    Ting JA; Barbir EB; McRae SA; Schachter M; De Luca L; Riazy M; Levin A
    Can J Kidney Health Dis; 2023; 10():20543581231153217. PubMed ID: 36794121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
    Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
    Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Case of scleroderma with rapid progressive glomerulonephritis associated with both MPO-ANCA and anti-GBM antibodies].
    Namba T; Hatanaka M; Takahashi A; Takeji M; Takahara K; Uzu T; Yamauchi A
    Nihon Jinzo Gakkai Shi; 2008; 50(1):64-8. PubMed ID: 18318246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Sequential Development of Antiglomerular Basement Membrane Nephritis and Myeloperoxidase-antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    Ohashi N; Namikawa A; Ono M; Iwakura T; Isobe S; Tsuji T; Kato A; Yasuda H
    Intern Med; 2017 Oct; 56(19):2617-2621. PubMed ID: 28883245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A relapsing case of pulmonary-renal syndrome after a sequential rise in MPO-ANCA and anti-GBM antibodies.
    Hoshino A; Sakairi T; Kayakabe K; Baba M; Ando M; Kimura H; Motohashi R; Nojima Y; Hiromura K
    CEN Case Rep; 2019 Aug; 8(3):221-225. PubMed ID: 30945174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
    Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
    Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANCA-GBM dot-blot test in diagnosis of patients with glomerulonephritis.
    Milovanceva-Popovska M; Grcevska L; Dzikova S; Ristovska V; Petrusevska G; Stefanovski K; Tervaert JW; Polenakovic M
    Prilozi; 2006 Jul; 27(1):45-55. PubMed ID: 16862065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of rapidly progressive glomerulonephritis associated with both antineutrophil cytoplasmic antibody-associated vasculitis and anti-glomerular basement membrane nephritis in the course of nontuberculous mycobacterium infection: a case report.
    Kato M; Wakiya R; Kameda T; Inoue K; Sofue T; Ushio Y; Sugihara K; Nakashima S; Shimada H; Mansour MMF; Kadowaki N; Dobashi H
    BMC Rheumatol; 2020 Dec; 4(1):68. PubMed ID: 33308324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case presenting with the possible relationship between myeloperoxidase-antineutrophil cytoplasmic antibody-associated glomerulonephritis and membranous changes of the glomerular basement membrane.
    Uyama S; Ohashi N; Iwakura T; Ono M; Fujikura T; Sakao Y; Yasuda H; Kato A; Fujigaki Y
    CEN Case Rep; 2013 May; 2(1):53-58. PubMed ID: 28509220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a Rat Model of Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Crescentic Glomerulonephritis.
    Cerullo D; Rottoli D; Corna D; Rizzo P; Abbate M; Macconi D; Benigni A; Remuzzi G; Zoja C
    Nephron; 2021; 145(4):428-444. PubMed ID: 33910203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.